Exagen Inc.
XGN
$3.02
-$0.15-4.73%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.67M | -7.09M | -4.44M | -3.75M | -3.76M |
| Total Depreciation and Amortization | 600.00K | 612.00K | 466.00K | 440.00K | 415.00K |
| Total Amortization of Deferred Charges | 131.00K | 126.00K | 79.00K | 42.00K | 42.00K |
| Total Other Non-Cash Items | -370.00K | 3.33M | 2.13M | 725.00K | 731.00K |
| Change in Net Operating Assets | 1.30M | 5.96M | -1.12M | -8.13M | 2.94M |
| Cash from Operations | -3.01M | 2.94M | -2.89M | -10.67M | 363.00K |
| Capital Expenditure | -44.00K | -275.00K | -209.00K | -113.00K | -146.00K |
| Sale of Property, Plant, and Equipment | 9.00K | 0.00 | 0.00 | 6.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -35.00K | -275.00K | -209.00K | -107.00K | -146.00K |
| Total Debt Issued | 0.00 | 0.00 | 23.67M | -- | -- |
| Total Debt Repaid | -346.00K | -336.00K | -19.85M | -262.00K | -216.00K |
| Issuance of Common Stock | -- | 3.49M | 18.78M | 198.00K | 0.00 |
| Repurchase of Common Stock | -38.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -199.00K | -670.00K | -- | -- |
| Cash from Financing | -384.00K | 2.95M | 21.93M | -64.00K | -216.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.43M | 5.62M | 18.84M | -10.84M | 1.00K |